Olympus Announces Co-Development Agreement with AI4GI

Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, announced its co-development agreement with AI4GI, a commercial joint venture between Satis Operations and Imagia. Their Artificial Intelligence (AI) solution for real-time clinical decision support during screening and surveillance colonoscopy procedures will be exclusively offered by Olympus America Inc. (OAI). This co-development agreement is intended to raise the bar for all physicians to ultimately improve clinical outcomes, reduce overall costs and enhance the quality of life for patients. 

Related posts

Imagia Partners with Top US and Canadian Hospitals to Facilitate AI Accelerated Healthcare Discoveries

Imagia Partners with Top US and Canadian Hospitals to Facilitate AI Accelerated Healthcare Discoveries

New partnerships enable hospitals to access the Imagia EVIDENS™ AI platform, empowering clinicians to utilize cohorted and structured real

...
Read more
$2.6M to fight cancer using innovative technologies and artificial intelligence

$2.6M to fight cancer using innovative technologies and artificial intelligence

Created by leading financiers wanting to combine academic research and industry expertise, the Onco-Tech Competition is an opportunity for Q

...
Read more
The Promise of Prescribing AI to Cure Lung Cancer

The Promise of Prescribing AI to Cure Lung Cancer

In a forest of data, AI can find abnormalities within seconds. Now apply this principle to finding atypical cancer cells among the healthy o

...
Read more